https://scitechdaily.com/beyond-blood-sugar-control-new-target-for-curing-diabetes-unveiled/
By Helmholtz Munich March 22, 2024. Targeting the inceptor receptor could lead to breakthrough treatments for diabetes by protecting beta cells and improving blood sugar control, with German research institutions leading this promising discovery. Insulin-producing beta cells in the islet of Langerhans. Credit: Helmholtz Munich | Erik Bader.

https://www.nbcnews.com/nightly-news/video/promising-new-study-using-diet-changes-to-treat-type-2-diabetes-141732933734
A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet changes to target the fat around organs like

https://www.sciencedaily.com/releases/2021/06/210629191737.htm
Researchers believe the liver may hold the key to new, preventative Type 2 diabetes treatments. This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that

https://www.healthline.com/health-news/intermittent-fasting-can-help-people-with-type-2-diabetes-control-blood-sugar-weight-loss
Share on Pinterest A new study found that intermittent fasting could help people with type 2 diabetes lose weight and lower blood sugar levels. FG Trade/Getty Images A study compared 5:2

https://www.medicalnewstoday.com/articles/a-dna-diet-may-help-reduce-type-2-diabetes-risk-new-study-argues
Image credit: Maja Topcagic/Stocksy. New research suggests that a diet tailored to an individual's DNA profile could play a role in managing blood sugar levels and reducing the risk of

https://www.nature.com/articles/s41598-022-05127-9
Diet plays an important role in shaping the intestinal microbiota and the gut responds very rapidly to alterations in diet 6,7, thus diet may serve as a potential new target for disease control

https://www.news-medical.net/news/20230803/Reversing-ceb2-cell-failure-A-promising-approach-for-type-2-diabetes-treatment.aspx
Conclusion. Based on the review findings, beta-cell failure is caused by stress, factors like ER and oxidative stress, mitochondrial dysfunction, and alterations in beta-cell identity. To address

https://pubmed.ncbi.nlm.nih.gov/38904963/
Importance: An intermittent fasting plan consisting of 2 nonconsecutive fasting days and 5 days of habitual intake per week and meal replacement diet (5:2 MR) could provide additional benefits to patients with type 2 diabetes. Objective: To evaluate the effect of the 5:2 MR on glycemic control among patients with early type 2 diabetes compared with metformin and empagliflozin.

https://www.sciencedaily.com/releases/2022/05/220523093353.htm
New findings detail the 21-year follow-up of more than 3,200 adults with prediabetes who had participated in the original Diabetes Prevention Program trial. The DPPOS confirmed that treatment

https://www.mountsinai.org/about/newsroom/2022/researchers-identify-potential-target-for-treatment-among-patients-with-type-two-diabetes
Our findings provide a foundation for preserving existing β-cell mass and for developing new therapeutic approaches that have the potential to successfully prevent thousands of type 2 diabetes patients from progressing to insulin dependence," said the study's lead author Liora S. Katz, PhD, Assistant Professor of Medicine at Icahn Mount Sinai.

https://medicine.weill.cornell.edu/news/new-study-reveals-promising-findings-treat-type-2-diabetes
A new study published in the Journal of Clinical Investigation has demonstrated that activating a pathway to promote cell division not only expanded the population of insulin-producing cells, but, surprisingly, also enhanced the cells' function. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more

https://www.news-medical.net/news/20220518/Using-diet-as-a-primary-intervention-to-achieve-remission-of-type-2-diabetes-in-adults.aspx
Titled "Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission," the expert consensus statement was written by a multidisciplinary panel of 15 experts using a

https://www.uab.edu/news/research/item/12306-uab-trial-studying-diet-composition-with-no-weight-loss-to-treat-type-2-diabetes
Email. The study, led by Barbara Gower, Ph.D., is the first randomized clinical trial of a hypothesis that reducing fat stored around organs, through diet alone, can rescue beta-cell function. A clinical trial now enrolling at the University of Alabama at Birmingham is taking an unusual approach to help patients with Type 2 diabetes.

https://diabetes.org/newsroom/late-breaking-weight-loss-innovations-new-drug-therapies-shown-offer-positive-outcomes-obesity-type-2-diabetes-management
We have seen an explosion of promising new research and innovations in this field in recent years," said Dr. Robert Gabbay, chief scientific and medical officer for the ADA. ... Oral semaglutide is available at 14 mg for the treatment of type 2 diabetes (T2D); however, the OASIS 1 study is the first time it has been investigated for both the

https://www.medicalnewstoday.com/articles/how-a-52-intermittent-fasting-diet-can-help-people-with-type-2-diabetes
A study from China suggest that a 5:2 intermittent fasting diet with meal replacement may be helpful for people with type 2 diabetes.; Researchers reported that participants on the eating plan had

https://www.euronews.com/health/2024/06/24/intermittent-fasting-may-help-type-2-diabetics-control-blood-sugar-study
By the end of the 16-week study, participants who adopted the 5:2 diet saw a blood sugar level reduction of 1.9 per cent, compared with 0.3 per cent and 0.4 per cent among those who took the drugs.

https://time.com/6197414/type-2-diabetes-latest-advancements/
Surgery led to diabetes remission in roughly 28% of patients, compared with a remission rate of just 4% among the non-surgery group, according to the study results. More research has found that

https://www.hsph.harvard.edu/news/press-releases/study-links-gut-microbiome-changes-to-increased-risk-of-type-2-diabetes/
"We believe that changes in the gut microbiome cause type 2 diabetes," said Wang. "The changes to the microbiome may happen first, and diabetes develops later, not the other way around—although future prospective or interventional studies are needed to prove this relation firmly."

https://www.sciencedirect.com/science/article/pii/S2213858721001133
Summary. Despite the successful development of new therapies for the treatment of type 2 diabetes, such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 inhibitors, the search for novel treatment options that can provide better glycaemic control and at reduce complications is a continuous effort.

https://www.nbc.com/nbc-nightly-news/video/promising-new-study-using-diet-changes-to-treat-type-2-diabetes/NBCN732933734
Watch NBC Nightly News with Lester Holt excerpt: Promising new study using diet changes to treat type 2 diabetes - NBC.com

https://www.sciencedaily.com/releases/2022/02/220201144001.htm
Date: February 1, 2022. Source: Scripps Research Institute. Summary: A team of scientists has conducted promising early tests of a new strategy that might one day be used to prevent or treat type

https://talkingdiabetes.com/2023/03/09/promising-new-study-using-diet-changes-to-treat-type-2-diabetes/
A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet changes to target the fat around organs like the pancreas and liver. Researcher Barbara Gower speaks to how Americans tend to eat more sugar and carbohydrates in their diet. After awhile, the

https://www.healthline.com/health/type-2-diabetes/diet-changes-newly-diagnosed
nuts and seeds, such as almonds and sunflower seeds. lean sources of protein, such as chicken and lean cuts of pork. fish and eggs. dairy products, such as unsweetened yogurt. However, depending

https://diabetes.org/newsroom/press-releases/american-diabetes-association-highlights-innovations-new-drug-therapies
"This study matters because many people living with type 2 diabetes are taking multiple diabetes medications to try to reach blood sugar targets, and new medications that have the potential to help simplify treatment regimens are needed," said Melissa K. Thomas, MD, PhD, Vice President, Diabetes and Metabolic Research, Lilly Research

https://www.dpo.uab.edu/shp/drc/news-events/latest-drc-news/promising-new-study-using-diet-changes-to-treat-type-2-diabetes
Promising New Study Using Diet Changes To Treat Type 2 Diabetes Details Published: July 21st, 2022 A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet changes to target the fat around organs like the pancreas and liver. ... Promising New Study

https://www.youtube.com/watch?v=-vEcU66tvlI
Nutritionist Maya Feller discusses what to know about the new findings that some people were able to put their Type 2 diabetes into remission using a rigorou

https://www.youtube.com/watch?v=kqkhj653nIs
A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet change

https://www.ipf.uab.edu/shp/drc/news-events/latest-drc-news/promising-new-study-using-diet-changes-to-treat-type-2-diabetes
SHP Insight, Vol. 10: W. Timothy Garvey - obesity, diabetes and more

https://www.facebook.com/nbcnightlynews/videos/promising-new-study-using-diet-changes-to-treat-type-2-diabetes/792627455054376/
A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet changes to target the fat around organs like the pancreas and liver.

https://www.niehs.nih.gov/sites/default/files/2024-06/breast_cancer_why_the_environment_matters_508_1.pdf
Metformin use. While no association between type 2 diabetes . and risk of developing estrogen receptor-positive breast cancer . was found, there was a small increase in estrogen receptor-negative and triple-negative breast cancer among those with type 2 diabetes. Most women in the study with type 2 diabetes took metformin, a medication widely